PNC Financial Services Group’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $19.5K | Buy |
1,678
+297
| +22% | +$3.46K | ﹤0.01% | 3582 |
|
2025
Q1 | $10.3K | Buy |
1,381
+14
| +1% | +$104 | ﹤0.01% | 3814 |
|
2024
Q4 | $8.2K | Sell |
1,367
-1,625
| -54% | -$9.74K | ﹤0.01% | 3867 |
|
2024
Q3 | $15.3K | Sell |
2,992
-4,400
| -60% | -$22.5K | ﹤0.01% | 3633 |
|
2024
Q2 | $26.8K | Sell |
7,392
-2,037
| -22% | -$7.37K | ﹤0.01% | 3336 |
|
2024
Q1 | $30.3K | Buy |
9,429
+1,615
| +21% | +$5.18K | ﹤0.01% | 3235 |
|
2023
Q4 | $38.3K | Sell |
7,814
-328
| -4% | -$1.61K | ﹤0.01% | 3098 |
|
2023
Q3 | $44.4K | Sell |
8,142
-290
| -3% | -$1.58K | ﹤0.01% | 3024 |
|
2023
Q2 | $56.6K | Buy |
8,432
+1,587
| +23% | +$10.6K | ﹤0.01% | 2989 |
|
2023
Q1 | $60.4K | Sell |
6,845
-41
| -0.6% | -$362 | ﹤0.01% | 2875 |
|
2022
Q4 | $52.6K | Sell |
6,886
-1,990
| -22% | -$15.2K | ﹤0.01% | 2954 |
|
2022
Q3 | $64K | Buy |
8,876
+4,977
| +128% | +$35.9K | ﹤0.01% | 2808 |
|
2022
Q2 | $32K | Sell |
3,899
-1,394
| -26% | -$11.4K | ﹤0.01% | 3245 |
|
2022
Q1 | $73K | Buy |
5,293
+3,380
| +177% | +$46.6K | ﹤0.01% | 2889 |
|
2021
Q4 | $53K | Sell |
1,913
-3,333
| -64% | -$92.3K | ﹤0.01% | 3076 |
|
2021
Q3 | $179K | Sell |
5,246
-2,472
| -32% | -$84.3K | ﹤0.01% | 2266 |
|
2021
Q2 | $315K | Sell |
7,718
-2,042
| -21% | -$83.3K | ﹤0.01% | 1934 |
|
2021
Q1 | $393K | Sell |
9,760
-164
| -2% | -$6.6K | ﹤0.01% | 1735 |
|
2020
Q4 | $588K | Buy |
9,924
+3,562
| +56% | +$211K | ﹤0.01% | 1381 |
|
2020
Q3 | $309K | Sell |
6,362
-273
| -4% | -$13.3K | ﹤0.01% | 1655 |
|
2020
Q2 | $322K | Buy |
6,635
+5,986
| +922% | +$291K | ﹤0.01% | 1632 |
|
2020
Q1 | $18K | Buy |
649
+11
| +2% | +$305 | ﹤0.01% | 3160 |
|
2019
Q4 | $19K | Sell |
638
-3
| -0.5% | -$89 | ﹤0.01% | 3326 |
|
2019
Q3 | $20K | Buy |
+641
| New | +$20K | ﹤0.01% | 3341 |
|